Saturday, March 15, 2025
6.6 C
London
HomeFinTechMedibio: Launches $1.4m placement, CEO resigns

Medibio: Launches $1.4m placement, CEO resigns

Date:

ABN AMRO-Owned Neobroker Fined $1.6M for Paying Finfluencers

A Significant Penalty in the Financial Industry Highlights Regulatory...

AvidXchange Explores Potential Sale Amid Market Changes

What Investors Need to Know About AvidXchange's Strategic ShiftHighlights:...

Raisin Expands Its Offerings by Launching in Finland

Discover how Raisin is transforming the financial landscape in...

Medibio Launches $1.4m placement, CEO resigns

  • Medibio (MEB) receives firm commitments to raise $1.4 million via placement to fund its US Food and Drug Administration (FDA) application and for working capital
  • The company will issue approximately 923.6 million shares at 0.15 cents over two tranches, with the offer of one free-attaching option for every one new share issued
  • Additionally, Claude Solitario has resigned as CEO and Managing Director to pursue other business interests, effective today
  • The search for a new CEO will commence shortly and the company confirms it will update the market in due course
  • Shares in the company are down 33.3 per cent, trading at 0.2 cents as of 1:51 pm AEST

Related stories

spot_img

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories